- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04899362
The Impact of Serial Remote Ischemic Conditioning on Dynamic Cerebral Autoregulation in Healthy Adults
December 14, 2023 updated by: The First Hospital of Jilin University
The purpose of this study is to determine the impact of serial remote ischemic conditioning on dynamic cerebral autoregulation and related hematology indexes in healthy adults.
Study Overview
Status
Completed
Conditions
Detailed Description
Remote ischemic conditioning(RIC) is the phenomenon whereby brief cycles of ischemia and reperfusion, applied to a distant organ, provide protection to the target organ.
Dynamic cerebral autoregulation(dCA), a mechanism to maintain the cerebral blood flow, has been proved to be critical for the occurrence,development and prognosis of ischemic neurovascular disease.
In this study, we hypothesis that RIC provides neuro-protection by means of improving dCA.
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Jilin
-
Changchun, Jilin, China, 130000
- First Hospital of Jilin University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- age from 18 to 50,both genders
- willing to participate in follow-up visits
Exclusion Criteria:
- current or having a history of chronic physical diseases or mental diseases
- suffering from infectious diseases in late one month
- pregnant and lactating women#
- smoking or drinking#
- inability to cooperate sufficiently to complete the dCA examination
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: RIC group
RIC was induced by 4 cycles of extremities ischemia (5-minute blood-pressure cuff inflation to 200 mm Hg, followed by 5-minute cuff deflation).All subjects will take 14 RIC intervention, blood collection and 10 dCA measurements.
|
The RIC consisted of 4 cycles of extremities ischemia (5-minute blood pressure cuff inflation to 200 mm Hg, followed by 5-minute cuff deflation).
The tourniquets were applied to one side upper arm.
This intervention was undertaken twice a day for 7 days.
Nurses will collect intravenous blood 3ml four times (at baseline and the first, seventh and eighth day of the study).The blood samples will be stored for laboratory test.The blood samples only use for the trial.
Serial measurements of dCA were performed at 10 days, baseline, 1st, 2ed, 4th, 7th, 8th, 10th, 14th, 21th and 35th of the study.The continuous ABP was measured non-invasively using a servo-controlled plethysmograph (Finometer Pro, the Netherlands) at the middle finger.
Two 2 MHz transcranial Doppler probe was used to measure continuous cerebral blood flow velocity (CBFV) simultaneously in the bilateral middle cerebral arteries at a depth of 45-60 mm Endtidal CO2 was monitored using a capnograph (MultiDop X2, DWL, Sipplingen, Germany).
The probes were placed over temporal windows and fixed with a customized head frame.
CBFV and continuous arterial blood pressure were recorded simultaneously from each subject in the supine position for 10 minutes.
All data were recorded for further assessment and analysis.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dynamic Cerebral Autoregulation Parameter: Phase Difference(PD) in Degree
Time Frame: 36 days
|
Dynamic cerebral autoregulation (dCA) is an important indicator of cerebrovascular function which related to the prognosis of cerebrovascular disease.
DCA is usually calculated by transfer function analysis.
Phase Difference (PD) is gengreated.
Low PD at a low frequency band indicates impairment of autoregulation, as it suggests that cerebral blood flow velocity follows the changes in arterial blood pressure with a short delay.
|
36 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dynamic Cerebral Autoregulation Parameter: Gain in cm/s/mmHg
Time Frame: 36 days
|
High gain at the same frequency band is also considered an indicator of compromised autoregulation for passively transferring the amplitude of arterial blood pressure to cerebral blood flow velocity.
|
36 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 20, 2021
Primary Completion (Actual)
July 19, 2021
Study Completion (Actual)
July 30, 2021
Study Registration Dates
First Submitted
May 10, 2021
First Submitted That Met QC Criteria
May 20, 2021
First Posted (Actual)
May 24, 2021
Study Record Updates
Last Update Posted (Estimated)
January 3, 2024
Last Update Submitted That Met QC Criteria
December 14, 2023
Last Verified
May 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SRIC-CA
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Remote Ischemic Conditioning
-
Yi YangRecruitingRemote Ischemic ConditioningChina
-
Yi YangRecruitingRemote Ischemic ConditioningChina
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruitingCoronary Artery Bypass Grafting | Remote Ischemic ConditioningChina
-
Capital Medical UniversityUnknownPrehypertension | Remote Ischemic Conditioning | Early Stage HypertensionChina
-
Yi YangCompletedRemote Ischemic ConditioningChina
-
East Carolina UniversityRecruitingHemiplegic Cerebral Palsy | Unilateral Cerebral Palsy | Remote Ischemic ConditioningUnited States
-
University of Cape TownUniversity College, London; Kenyatta National Hospital; Uganda Heart Institute; Grey's Hospital and other collaboratorsRecruitingMyocardial Reperfusion Injury | STEMI | Remote Ischaemic ConditioningKenya, Uganda, South Africa, Sudan
-
Huashan HospitalNot yet recruitingMoyamoya Disease | Remote Ischemic Conditioning
-
Xuzhou Medical UniversityCompletedMyocardial Injury | Remote Ischemic PreconditioningChina
-
Seoul National University HospitalCompletedRemote Ischemic PreconditioningKorea, Republic of
Clinical Trials on BB-RIC-D1/LAPUL Medical Devices Co, Ltd, China
-
The First Affiliated Hospital with Nanjing Medical...Active, not recruiting
-
Air Force Military Medical University, ChinaNational Natural Science Foundation of ChinaUnknownCongenital Heart DefectsChina
-
Xiangya Hospital of Central South UniversityNot yet recruitingIntracranial Hypertension | Critical Care | Monitoring | Treatment Outcome | Cerebral Hemorrhage, Hypertensive | Bioelectrical Impedance AnalysisChina
-
Montefiore Medical CenterNot yet recruitingAirway Management | Laryngeal Mask Airways | Supraglottic Airways | Video-assistedUnited States